Early Pancreatic Cancer: Blood Test Indicators and What They Mean

Certain blood markers may suggest early pancreatic cancer but are not definitive; they must be interpreted alongside imaging and clinical findings.

Potential Indicators

• CA 19-9: Elevated in pancreatic cancer but also in benign pancreatic/biliary conditions.
• CA 125: May rise in advanced disease; also elevated in gynecologic cancers and inflammation.
• Bilirubin (especially direct): Increases if tumor obstructs bile duct (obstructive jaundice), accompanied by elevated ALP and GGT.
• Liver enzymes (ALT, AST, ALP): Elevated if cancer spreads to liver.
• Blood glucose: New-onset diabetes or worsening control can signal pancreatic cancer.
• CBC changes: Anemia, leukocytosis, abnormal platelets may reflect malignancy-related inflammation or blood loss.

These markers lack specificity; always correlate with imaging (CT, MRI, EUS) and biopsy for diagnosis.